https://clinicaltrials.gov/ct2/show/NCT03817424?type=Intr&cond=Lupus&phase=012345&lupd_s=01%2F11%2F2019&lupd_d=14
Conditions : Systemic Lupus Erythematosus; Cutaneous Lupus Erythematosus; Sjogren’s Syndrome; Systemic Sclerosis; Polymyositis; Dermatomyositis
Interventions : Drug: VIB7734; Drug: Placebo
Sponsor : Viela Bio
Recruiting
A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren’s Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
NCT03817424
Fri, 25 Jan 2019 12:00:00 EST
